Skip to search.
 NZX 50 Down 0.25%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
6.42 29 Aug 08:00
Add to Portfolio
Prev Close:6.42
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:15.30
Beta:6.69727
Earnings Date:4 Nov - 9 Nov (Est.)
Day's Range:N/A - N/A
52wk Range:5.25 - 18.42
Volume:0
Avg Vol (3m):1,596,240
Market Cap:675.20m
P/E (ttm):N/A
EPS (ttm):-1.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERX 0.00%675.20m
BAX21.14b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):149.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.02
Quarterly EPS Est (Sep-15) :-0.26
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback